Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724709 | SCV000227293 | uncertain significance | not provided | 2015-04-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000225714 | SCV000236402 | benign | not specified | 2014-09-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001079627 | SCV001010181 | likely benign | Hypertrophic cardiomyopathy 25; Primary familial hypertrophic cardiomyopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000225714 | SCV001432027 | benign | not specified | 2020-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426843 | SCV002743528 | likely benign | Cardiovascular phenotype | 2019-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |